Women with sickle cell disease have a significantly higher likelihood of developing preeclampsia than the general population, but a blood test could identify which patients have the greatest risk.A ...

The targeted radiotherapies for cancer market is experiencing significant growth, driven by advancements in technology and ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

Intellia faces FDA clinical holds on key ATTR studies as it readies crucial HAE data in 2026, making lonvo-z pivotal for its near-term outlook.

SCD is an inherited blood disorder that affects millions of children worldwide, particularly in India and sub-Saharan Africa, ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...

A Gurugram hospital study reveals significant success in curing Sickle Cell Disease among children through bone marrow ...

WXII is partnering with the American Red Cross for a community blood drive, and the need couldn't be more urgent.You can make ...

Gurugram: Indian healthcare, doctors at FMRI, Gurugram, have reported exceptional success in curing children suffering from ...